Covered recipient · General Payments record
DAVID ARTHUR BROWNE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2020–2025
$1,438.53
- Reported across 38 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.52 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ITI, Inc. | $145.28 | 2 |
| Vanda Pharmaceuticals Inc. | $125.00 | 1 |
| Alkermes, Inc. | $120.89 | 1 |
| Otsuka America Pharmaceutical, Inc. | $98.82 | 1 |
| ABBVIE INC. | $27.75 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.04 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201572152 | CMS |
| ABBVIE INC. | $13.71 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201572154 | CMS |
| Alkermes, Inc. | $120.89 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222455177 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.28 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241262282 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $130.00 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241262284 | CMS |
| Otsuka America Pharmaceutical, Inc. | $98.82 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227301318 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.78 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223864229 | CMS |
| Vanda Pharmaceuticals Inc. | $125.00 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232952480 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.